Estrogen exerts classical genomic as well as rapid nongenomic actions on neurons. The mechanisms involved in rapid estrogen signaling are poorly defined, and the roles of the classical estrogen receptors (ERs ␣ and ␤) are unclear. We examined here the in vivo role of classical ERs in rapid estrogen actions by evaluating the estrogen-induced effects on two major signaling pathways within the brains of ␣ER-, ␤ER-, and double ␣␤ER-knockout (ERKO) ovariectomized female mice. Estrogen significantly (P < 0.05) increased the numbers of phospho-cAMP response element binding protein (phospho-CREB)-immunoreactive cells in specific brain regions of wild-type mice in a time-dependent manner beginning within 15 min. In brain areas that express predominantly ER␤, this response was absent in ␤ERKO mice, whereas brain regions that express mostly ER␣ displayed no change in ␣ERKO mice.
In the medial preoptic nucleus (MPN), an area that expresses both ERs, the estrogen-induced phosphorylation of CREB was normal in both ␣ERKO and ␤ERKO mice. However, estrogen had no effect on CREB phosphorylation in the MPN, or any other brain region, in double ␣␤ERKO animals. Estrogen was also found to increase MAPK phosphorylation levels in a rapid (<15 min) manner within the MPN. In contrast to CREB signaling, this effect was lost in either ␣ERKO or ␤ERKO mice. These data show that ER␣ and ER␤ play region-and pathwayspecific roles in rapid estrogen actions throughout the brain.
They further indicate an indispensable role for classical ERs in rapid estrogen actions in vivo and highlight the importance of ERs in coordinating both classical and rapid actions of estrogen. (Endocrinology 145: 3055-3061, 2004)
E STROGEN EXERTS POTENT modulatory effects on multiple neuronal networks. Recent studies documenting effects of estrogen on cognition, mood, motor control, and ischemic brain damage (1) have extended the significance of estrogen actions outside its roles in reproductive circuitry (2) . Although it is clear that many of the effects of estrogen on neuronal functioning are mediated classically by transcriptional actions of estrogen receptor (ER) ␣ and ER␤, rapid nongenomic effects of estrogen are now also recognized (1, 3) . The mechanisms underlying these rapid effects of estrogen are not clear, and considerable controversy exists regarding the location and identity of the receptors responsible for these responses.
Evidence for a critical role for classical ERs in the rapid effects of estrogen on the MAPK/ERK signaling pathway has been found in multiple cell types (4 -8) . Furthermore, recent studies have reported that only the ligand binding region of ER␣ is required for estrogen activation of the Src/Shc/ERK signaling pathway in bone (9) . However, estrogen modulates the activity of multiple intracellular signaling pathways, and in vitro studies have suggested that the rapid actions of estrogen on calcium (10, 11) , protein kinase A/cAMP (12, 13) , protein kinase C (14, 15) , and neocortical MAPK (16) pathways may require a novel estrogen-binding receptor. In specific instances, estrogen has been shown to allosterically modulate known ion channels (17) or neurotransmitter receptors (18, 19) , but, for the most part, the molecular mechanisms underlying rapid estrogen actions on the brain are unclear.
In the present study, we have used the ER␣-and ER␤-knockout (ERKO) mice to examine in a definitive manner the relationship between the classical ERs and rapid estrogen actions on intracellular signaling cascades within the brain in vivo. The phosphorylation of cAMP response element binding protein (CREB) represents a major site of intracellular signal integration (20) and is influenced by all of the signaling cascades so far implicated in rapid estrogen actions. Accordingly, estrogen has been shown to alter CREB phosphorylation rapidly within many regions of the brain (21) (22) (23) . As such, we have used the phosphorylation of CREB as a marker of activity in diverse intracellular signaling pathways to examine the impact of deletion of ER␣ or ER␤ or both ERs on rapid estrogen actions in the brain in vivo. For comparison, we also evaluated the rapid effects of estrogen on MAPK/ ERK1/2 phosphorylation. We report here that all rapid effects of estrogen on CREB and MAPK activation were found Abbreviations: CREB, cAMP response element binding protein; E2, 17-␤-estradiol; ER, estrogen receptor; ERKO, ER-knockout; gCTX, granulate cortex; MPN, medial preoptic nucleus; OVX, ovariectomized; pCREB, phospho-CREB; vlVMN, ventrolateral aspect of the hypothalamic ventromedial nucleus.
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to be dependent on the presence of ER␣ or ER␤ or both in a brain region-specific and signaling pathway-specific manner.
Materials and Methods Animals
Nontransgenic (C57BL6/J ϫ CBA/Ca) and ERKO (C57BL6/J) (24, 25) 
Experimental design and protocol
Young adult female wild-type mice (C57BL6/J x CBA/Ca) were ovariectomized (OVX) at 40 -54 d of age under Avertin anesthesia and used for experiments 3 wk later. Between 1000 and 1100 h, mice were administered 1 or 10 g 17-␤-estradiol (E2; Sigma, Poole, UK; in 0.1 ml ethyl oleate vehicle, sc) or vehicle alone and killed 15 min, 1 h, or 4 h later by an overdose of Avertin (0.3 ml/20 g body weight) followed by perfusion through the heart with ice-cold 4% paraformaldehyde in phosphate buffer (pH 7.6) (n ϭ 5-6 per group). Brains were removed, postfixed for 2 h, and placed into 30% sucrose Tris-buffered saline solution overnight at 4 C. The next day, 1:4 series of 30-m-thick frozen sections were cut in the frontal plane on a sliding microtome.
Homozygous ␣ERKO, ␤ERKO, and ␣␤ERKO female mice and their wild-type siblings (C57BL6/J; n ϭ 5-6 per group) were treated in the same manner detailed above with the exception that they were only treated with the lower 1-g E2 dose or vehicle and killed 1 h later.
For estrogen time-and dose-dependent studies in wild-type mice, estrogen-and vehicle-treated mice were perfused alternatively. At each estrogen dose and time point, brain sections from pairs of estrogen-and vehicle-treated mice were processed together in the same wells to ensure identical immunostaining conditions. The raw data were then analyzed using ANOVA with Student-Newman-Keuls post hoc tests, and, for simplicity, data were presented as percentage of vehicle control. For ERKO mice, experiments were undertaken by alternate perfusion of estrogen-and vehicle-treated mice (n ϭ 5-6) from ␣ERKO, ␤ERKO, and wild-type littermates as three individual experiments. As before, brain sections from pairs of estrogen-and vehicle-treated mice were processed together in the same wells. The experiment with double ␣␤ERKO mice involved alternate perfusion of estrogen-and vehicle-treated wild-type mice and then ␣␤ERKO mice, and the paired processing of sections as above. Data from ERKO mice were analyzed with two-way ANOVA with Student-Newman-Keuls post hoc, and this smaller amount of data presented as direct cell counts. All statistical analyses were performed using Statistica for Windows 5.1 software (StatSoft; Statistica, Tulsa, OK).
Immunocytochemistry and analysis
Free-floating, peroxidase-based immunocytochemistry was undertaken in the same manner as reported previously (27) . In brief, after a 0.1% H 2 O 2 /40% methanol/Tris-buffered saline wash, one set of sections was incubated in each of the three polyclonal rabbit primary antibodies [phospho-CREB (pCREB), 1:100; CREB, 1:100; pMAPK/ERK1/2, 1:1000; Cell Signaling Technology, New England Biolabs, Beverly, MA] for 48 h at 4 C. This was followed by biotinylated goat antirabbit IgGs (1:200; Vector Laboratories, Peterborough, UK) for 2 h and the Vector Elite avidin-biotin-horseradish peroxidase complex (1:200) for 2 h. Labeling was then visualized with nickel-diaminobenzidine tetrahydrochloride.
The specificities of the CREB and MAPK antibodies have been reported previously in multiple rodent species (28) (Cell Signaling Technology data) including the mouse (29, 30) . The pCREB antibody detects CREB only when phosphorylated at Ser133 as well as phosphorylated forms of the CREB-related proteins activating transcription factor-1 and cAMP response element modulator. The pMAPK antibody is dual phosphospecific, detecting ERK1 only when phosphorylated at Thr202 and Tyr204 and ERK2 when phosphorylated at Thr183 and Tyr185. The omission of primary antibodies in this study resulted in a complete absence of immunoreactivity.
Sections were viewed under a Leica (Nussloch, Germany) DM-RB microscope, and a quantitative evaluation of the numbers of pCREB-and CREB-positive nuclei was undertaken by a blinded investigator using a computer-based imaging system (AIS 6.0, Rel. 1.3; Imaging Research, Inc., St. Catherines, Ontario, Canada) with the images digitized using a Sony (Tokyo, Japan) charge-coupled device (DXC 950P) camera. Five regions were selected for evaluation, depending on their known ER expression pattern in adult mice (31, 32) . This consisted of the ventrolateral aspect of the hypothalamic ventromedial nucleus (vlVMN; predominantly ER␣), the medial septum (exclusively ER␤), the medial preoptic nucleus (MPN; both ER␣ and ER␤), the retrosplenial granulate cortex (gCTX; minimal ER␤), and the caudate-putamen (no ER␣ or ER␤). The pMAPK immunoreactivity was restricted to a small number of brain regions and analyzed in the MPN and gCTX by the manual counting of immunoreactive cell numbers.
For each region, two sections were selected at the appropriate level (see below) in each mouse (n ϭ 5-6 per group), and bilateral cell counts were undertaken by counting all immunoreactive cell nuclei (CREB and pCREB) or cells exhibiting cytoplasmic staining (pMAPK) within a specified rectangle defined as follows: vlVMN, rectangle size 0. 
Results

Estrogen exerts rapid effects on CREB phosphorylation in vivo
Both CREB and pCREB immunoreactivities were restricted to the cell nucleus and found to be expressed widely throughout the brain (Fig. 1) . The administration of E2 to OVX wild-type C57BL6/J x CBA/Ca mice increased the numbers of cells expressing pCREB by up to 2-fold (P Ͻ 0.05) in the MPN (Figs. 1B and 2A ), medial septum (Fig. 2B) , and vlVMN (Fig. 2C) , but had no effect in the gCTX (data not shown) and caudate-putamen (Fig. 2D ). This occurred in the MPN and medial septum within 15 min and persisted at 1 and 4 h. Significantly increased numbers of pCREB-immunoreactive cells were only detected at 1 and 4 h in the vlVMN (Fig. 2) . The 1-and 10-g doses of E2 had the same effects on the magnitude of pCREB induction in all brain areas (Fig. 2) . In all cases, the numbers of CREB-immunoreactive cells were not changed by E2 (data not shown).
CREB phosphorylation critically depends on ERs in a brain region-specific manner
Estrogen treatment (1 g) had the same effects on pCREB expression in wild-type C57BL6/J siblings of ERKO mice (Fig. 3) as those observed above in C57BL6/J x CBA/Ca mice (Fig. 2) . In the MPN, E2 treatment resulted in a similar increase (P Ͻ 0.05) in pCREB cell numbers in wild-type, ␣ERKO, and ␤ERKO mice (Figs. 1C and 3A) . However, in the medial septum, the E2-induced increase in pCREB expression was found in wild-type and ␣ERKO mice but was absent in ␤ERKO mice (Fig. 3B) . In contrast, in the vlVMN, the estrogen-induced increase in pCREB was found in wild-type and ␤ERKO mice, but not ␣ERKO animals (Fig. 3C) . Basal pCREB levels, but not CREB itself, were significantly ele-vated in vehicle-treated ␣ERKO mice compared with vehicle-treated wild-type controls in the vlVMN (Fig. 3C) .
The results in the MPN suggested that classical ERs were not involved in the E2-dependent phosphorylation of CREB in this area or that, possibly, either receptor was sufficient. To examine this critical issue, we generated double ␣␤ERKO mice. We found that the E2-induced increase in pCREB within the MPN was completely absent in double ␣␤ERKO animals (Figs. 1D and 3A) . In fact, as predicted by the ER␣-and ER␤-dependent responses in the vlVMN and medial septum, respectively, estrogen had no effect on pCREB levels in any of the brain regions in double ␣␤ERKO mice (Fig. 3) . Basal levels of CREB were not different in vehicle-treated wild-type, ␣ERKO, ␤ERKO, or ␣␤ERKO mice and were not altered by estrogen treatment (data not shown).
Estrogen exerts rapid ER-dependent effects on MAPK phosphorylation in vivo
Immunoreactivity for pMAPK was localized throughout the cell (Fig. 4A) , and a strong signal was detected in the preoptic area, hypothalamic paraventricular and supraoptic nuclei, and bed nucleus of stria terminalis, with smaller numbers of positive cells found in the piriform cortex, central amygdala, thalamus, and gCTX. Using the exact same areas employed for the CREB analysis, we evaluated pMAPKimmunoreactive cell numbers in the MPN and gCTX. Treatment of wild-type C57BL6/J x CBA/Ca (Fig. 5, A and B) and C57BL6/J (Fig. 5C ) mice with E2 resulted in a significant 2.5-fold increase in the numbers of pMAPK-immunoreactive cells in the MPN, but had no effect in the gCTX (Fig. 5, E and  F) . The increase in the MPN was observed within 15 min (Fig.  5A ) and showed dose dependency (Fig. 5B) . The numbers of pMAPK-immunoreactive cells in the MPN were significantly reduced in vehicle-treated ␤ERKO mice compared with wild-type mice (Fig. 5C) . In marked contrast to pCREB regulation, the E2-induced increase in pMAPK was not detected in any of the ␣ERKO (Fig. 4B) , ␤ERKO (Fig. 4C) , or dual ␣␤ERKO genotypes (Fig. 5, C and D) .
Discussion
We report here that the rapid phosphorylation of CREB by estrogen in vivo has a critical requirement for classical ERs in the brain. Estrogen was completely unable to alter CREB phosphorylation in double ␣␤ERKO mice, and the established differential expression patterns of ER␣ and ER␤ in the mouse brain (31, 32) predicted the ER responsible for E2-dependent CREB phosphorylation in each brain region. The medial septum expresses ER␤ exclusively, and E2-induced CREB phosphorylation in this area was found to be dependent only on ER␤. Conversely, the vlVMN expresses predominantly ER␣, and CREB phosphorylation in these cells was dependent only on ER␣. Both the caudate-putamen and gCTX of mice express little, if any, ER␣ or ER␤ under normal circumstances (34) , and accordingly, we found no evidence for rapid estrogen effects on CREB phosphorylation in these areas. Interestingly, the rapid pCREB response to estrogen in the CA1 hippocampus of mice is absent only in ␤ERKO mice (27) . Taken together, these data suggest a tight correlation between classical ER expression and rapid estrogen signaling impacting on CREB within the brain. We suspect that this regional relationship also holds true for specific neuronal phenotypes within the brain. Specifically, the GnRH neurons of the hypothalamus express only ER␤ (35) , and we have shown recently that estrogen exerts rapid and direct effects on CREB phosphorylation in these neurons through a selective ER␤-mediated mechanism (27) .
Neurons of the MPN are known to coexpress ER␣ and ER␤ in the mouse (36) and rat (37), and we find here that either of these receptors can mediate the phosphorylation of CREB in the absence of the other within MPN cells. We initially observed that the E2-induced phosphorylation of CREB was unaltered in either ␣ERKO or ␤ERKO mice. At first sight, this suggested that E2 was acting through a mechanism independent of ER␣ and ER␤ to alter CREB phosphorylation. However, the possibility remained that each ER was compensating for the loss of the other, and, to address this issue, we generated double ␣␤ERKO mice. The complete lack of rapid estrogen actions on CREB phosphorylation in the MPN observed in double ␣␤ERKO mice confirmed the latter possibility. This result also indicated that any residual ER␣ activity in the ␣ERKO mice used here (38) was not functional in the context of rapid estrogen actions. The ability to switch between ERs is probably not a unique property of MPN cells because we have also observed the same pattern of ER dependence in the anteroventral periventricular area, another preoptic brain region where cells express both ERs. Although studies in endothelial cells have shown that only ER␣ can mediate rapid estrogen actions on phosphatidylinositol 3-kinase/Akt signaling (39), other workers have suggested that ER␣ and ER␤ may act in an interchangeable manner in vitro (4, 8, 40) . The present data provide in vivo evidence that cells expressing both ERs can use either receptor to respond to E2 in a rapid manner.
Surprisingly, we found here that both of the classical ERs are required for rapid estrogen actions on pMAPK within MPN cells. The two ERs may act independently at different points in the MAPK pathway or, perhaps more intriguingly, only function as heterodimers in this context. Certainly, it is established that ER␣ and ER␤ form heterodimers to regulate transcription (41) . In contrast, we noted that basal levels of pMAPK were dependent on ER␤ alone in the MPN. Thus, any role of classical ERs in the maintenance of MAPK signaling may be different from those involved in their rapid estrogen-dependent activation. Although we have only been able to examine restricted brain regions, this is the first evaluation of rapid estrogen actions on the pMAPK/ERK1/2 pathway in vivo. These results show a previously unrecognized complexity in the mechanisms underlying rapid estrogen actions on the MAPK pathway but, overall, support the great majority of in vitro studies indicating a critical role for the classical ERs (4 -9).
The in vivo requirement for both ER␣ and ER␤ in estrogeninduced MAPK phosphorylation reported here is not consistent with neuronal in vitro data. Studies by Dorsa and colleagues (5) have shown that either ER␣ or ER␤ is sufficient for rapid E2-dependent MAPK phosphorylation in embryonic cortical neurons, whereas Toran-Allerand et al. (16) have suggested that a novel ER mediates the phosphorylation of MAPK by E2 in neonatal neocortical cells. We did not find robust pMAPK immunoreactivity in the precise cortical regions analyzed in those studies, so we are unable to make direct comparisons. The gCTX region, where we found no effects of estrogen on pMAPK, is reported to have very little, if any, ER expression (31, 32) . However, it is important to note that our work was undertaken in vivo in adult mice as opposed to perinatal rats. Furthermore, our observations may relate especially to cells such as those in the MPN known for coexpression of both ERs. In this regard, it may be of importance that the phosphorylation of CREB within MPN cells requires the presence of either ER, whereas the phosphorylation of MAPK needs both ER␣ and ER␤. Although we do not know if these responses are occurring within the same cell type in the MPN, it is intriguing to speculate that ERs MPN and gCTX (C, D, G, H) . The first set of data for each region (A and E) gives the pMAPK levels observed 15 min, 1 h, and 4 h after the administration of 10 g E2 to OVX wild-type mice. The second set of data (B and F) shows responses at 1 h after either 1 or 10 g E2 given to OVX wild-type mice. Data are presented as percentage of vehicle-control data for each time point and E2 dose. The third set of data (C and G) shows results in wild-type (WT), ␣ERKO, and ␤ERKO OVX mice 1 h after 1 g of E2 (black bars) or vehicle (V; white bars). The fourth set shows data for wild-type controls and double ␣␤ERKO OVX females also 1 h after 1 g of E2 (black bars) or vehicle (white bars). *, P Ͻ 0.05 compared with vehicle-treated mice in each genotype. ϩ, P Ͻ 0.05 compared with wild-type vehicle-treated mice (n ϭ 5-6 per group).
may be being used in a differential manner within the different signaling pathways in individual cells.
Estrogen exerts widespread effects on multiple neuronal networks, and it is agreed that both direct genomic and rapid nongenomic mechanisms of action exist (1) . We have shown here that classical ERs are critical for all of the rapid estrogen actions we have observed on CREB and MAPK phosphorylation. The convergence of many intracellular signaling pathways to ultimately phosphorylate CREB and MAPK (20) suggests the strong likelihood that ER␣ and ER␤ play critical roles in many, if not most, rapid estrogen effects in the brain. Because we observed many of these ER-dependent rapid estrogen actions in brain regions implicated in the control of reproduction, it seems likely that rapid estrogen actions are relevant for classical estrogen-receptive neural circuits in addition to the novel estrogen effects described elsewhere in the brain (1). More importantly, however, this work indicates a likely close relationship between the rapid and classical genomic actions of estrogen throughout the brain. A recent study by Vasudevan et al. (42) has demonstrated that the rapid effects of estrogen on a neuroblastoma cell line are required for the full expression of estrogen's genomic influence. Equally, Kousteni et al. (9) have speculated that distinct conformational states of classical ERs may mediate the nongenomic or direct transcriptional actions of estrogen on bone cells. With our present data highlighting the importance of ER␣ and ER␤ in rapid estrogen actions, these studies together demonstrate that the classical ER represents a critical coordination point for rapid and direct transcriptional actions of estrogen within cells in vivo.
